Filed pursuant to Rule 497(a)
Registration No. 333-181563
Rule 482ad
ARES CAPITAL CORPORATION ANNOUNCES PUBLIC OFFERING
New York, NY April 2, 2013Ares Capital Corporation (Nasdaq: ARCC) announced that it plans to make a public offering of 16,650,000 shares of its common stock. Ares Capital also plans to grant the underwriters an option to purchase up to an additional 2,497,500 shares of common stock. The offering of the shares will be made under Ares Capitals shelf registration statement (as amended), which was filed with, and declared effective by, the Securities and Exchange Commission.
Ares Capital expects to use the net proceeds of this offering to repay certain outstanding indebtedness under its debt facilities and, to the extent not used for such purpose, for general corporate purposes, which may include investing in portfolio companies in accordance with its investment objective.
Investors are advised to carefully consider the investment objective, risks, charges and expenses of Ares Capital before investing. The preliminary prospectus supplement dated April 2, 2013 and the accompanying prospectus dated August 16, 2012, which have been filed with the Securities and Exchange Commission, contain this and other information about Ares Capital and should be read carefully before investing.
BofA Merrill Lynch, J.P. Morgan, Morgan Stanley and UBS Investment Bank are acting as joint book-running managers for this offering.
The information in the preliminary prospectus supplement, the accompanying prospectus and this press release is not complete and may be changed. The preliminary prospectus supplement, the accompanying prospectus and this press release are not offers to sell any securities of Ares Capital and are not soliciting an offer to buy such securities in any state where such offer and sale is not permitted.
The offering may be made only by means of a preliminary prospectus supplement and an accompanying prospectus, copies of which may be obtained from BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus Department, or e-mail dg.prospectus_requests@baml.com; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Attention: Prospectus Department, 866-803-9204; Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, NY, 10014, Attn: Prospectus Department, tel.: (866) 718-1649 or e-mail prospectus@morganstanley.com; or UBS Investment Bank, Attn: Prospectus Department, 299 Park Avenue, New York, NY 10171, tel.: (888) 827-7275.
ABOUT ARES CAPITAL CORPORATION
Ares Capital is a leading specialty finance company that provides one-stop financing solutions to U.S. middle market companies and private equity sponsors. The Company originates and invests in senior secured loans, mezzanine debt and, to a lesser extent, equity investments through its national direct origination platform. Ares Capitals investment objective is to generate both current income and capital appreciation through debt and equity investments primarily in private companies. Ares Capital has elected to be regulated as a business development company and is externally managed by a wholly owned subsidiary of Ares Management LLC. Ares Management is a global alternative asset manager and a SEC-registered investment adviser with approximately $59 billion of committed capital under management as of December 31, 2012.
FORWARD-LOOKING STATEMENTS
Statements included herein may constitute forward-looking statements, which relate to future events or our future performance or financial condition. These statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results and conditions may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in our filings with the Securities and Exchange Commission. Ares Capital Corporation undertakes no duty to update any forward-looking statements made herein.
CONTACT
Carl G. Drake
Ares Capital Corporation
888-818-5298